CClinicalTrials.gg
CompletedNCT00639730Updated May 27, 2010

Use of the Atkins Diet for Children With Sturge Weber Syndrome

A Phase 1 interventional study of modified Atkins diet in Epilepsy and Sturge Weber Syndrome, sponsored by Johns Hopkins University. Completed at 1 site in United States. Open to participants aged 2 Years to 18 Years. Per ClinicalTrials.gov, last updated 2010-05-27.

Sponsored by Johns Hopkins University · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
5
Allocation
Non-randomized
Ages
2 Years to 18 Years
Sex
All
01

Study summary

This research is being done to find out if the Atkins Diet can be used safely and effectively to reduce seizures in children who have Sturge Weber syndrome.

The ketogenic diet is a proven therapy for epilepsy, but can be difficult to use in children. The Atkins Diet is a high fat, high protein, low carbohydrate diet introduced in the 1970s to help with weight loss. It is different from the ketogenic diet in four major ways: no calorie restriction, no fluid restriction, no protein restriction, and is easy to start outside the hospital. People on the Atkins Diet become ketotic (produce high levels of ketones, a certain substance in the body), like patients on the ketogenic diet, and the investigators believe this may lead to seizure control.

Children aged 2-18 with Sturge Weber syndrome and seizures at least monthly, who have used at least two anti-seizure drugs may join. 5 children in total will be enrolled.

Read the detailed description

If you agree to be in this study, we will ask you to do the following things:

Before the diet is started:

  • We will ask you to keep track of your child's seizures daily for 2 weeks before starting the Atkins diet and provide us with a 3-day food record as well.
  • Baseline blood (about 2 teaspoons) and urine work will be obtained.
  • We will give you a free copy of a carbohydrate-counting guide.
  • You will be asked to fill out a 3-day food record.

On the diet:

  • Give your child a daily calcium supplement and multivitamin.
  • Keep a daily seizure log.
  • Check urine for ketones (to make sure the diet is working) and specific gravity (to make sure your child is well hydrated) twice a week and when you come to clinic.
  • We will ask you to weigh your child at home every week, and we will weigh him or her when you come into clinic too.
  • Do not fluid restrict your child; please give plenty of carbohydrate-free fluids.
  • You will give 20 grams per day of carbohydrates. We will give you instructions on how to measure daily intake of carbohydrates.
  • We will not change medications for the first three months. Do not change your child's seizure medicines without checking with our doctors.
  • For the first three months, we ask you to avoid store-bought low-carbohydrate products (as they can have more carbohydrates than advertised).

After being on the diet for one month, Dr. Kossoff will contact you by telephone to discuss how your child is doing. You can also speak with one of our dietitians. We will discuss the 3-day food record with you

You will be asked to come to the clinic (outpatient center, 5th floor) for two follow-up visits:

  1. after being on the diet for 3 months and
  2. after being on the diet for 6 months.

During these visits you will meet with one of our doctors and a dietitian. We will review your child's seizure control and health. We may obtain blood (about 2 teaspoons). We will check your child's urine for ketones and specific gravity.

If the diet is helping beyond 6 months, we will help your child continue on the diet with clinic visits and labs as necessary, at a carbohydrate amount that is most helpful.

02

Conditions studied

  • Epilepsy
  • Sturge Weber Syndrome

Keywords

  • Epilepsy
03

Who can participate

Ages eligible
2 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • 2-18 years
  • Sturge Weber syndrome
  • Monthly seizures (at least)
  • Tried at least two anticonvulsants

Exclusion criteria

Exclusion Criteria:

  • Prior use of the Atkins or ketogenic diets
  • Patients with non-epileptic seizures (pseudoseizures) will be excluded
  • Patients that are pregnant or become pregnant during the study will be excluded
  • High cholesterol
04

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (estimated)

Study arms

  • Experimental
    A

    This is open-label - all patients are placed on the diet. There is no control or placebo arm.

    Dietary Supplement: modified Atkins diet

Interventions

  • Dietary supplementmodified Atkins diet

    High fat, low carbohydrate diet

05

What researchers measure

Primary outcomes

  1. Seizures

    Seizure frequency will be compared to baseline (pre-Diet).

    Time frame: 6 months

Secondary outcomes

  1. Ketosis

    Time frame: 6 months

  2. Safety (stroke like events)

    Time frame: 6 months

06

Study locations

1 site
  • Johns Hopkins Hospital
    Baltimore, Maryland 21287, United States
07

References and documents

Publications

  • Kossoff EH, Turner Z, Bluml RM, Pyzik PL, Vining EP. A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet. Epilepsy Behav. 2007 May;10(3):432-6. doi: 10.1016/j.yebeh.2007.01.012. Epub 2007 Feb 26. PubMed 17324628 ↗
  • Kossoff EH, McGrogan JR, Bluml RM, Pillas DJ, Rubenstein JE, Vining EP. A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy. Epilepsia. 2006 Feb;47(2):421-4. doi: 10.1111/j.1528-1167.2006.00438.x. PubMed 16499770 ↗
08

Registry details

Key details

Study ID
NCT00639730
Lead sponsor
Johns Hopkins University
Collaborators
Vascular Birthmarks Foundation
First posted
Mar 20, 2008
Start date
May 2006
Primary completion
Mar 2010
Completion
May 2010
Last update
May 27, 2010

Study contacts

Eric H Kossoff, MD
principal investigator · Johns Hopkins School of Medicine

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2010. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion